神经内分泌肿瘤临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 神经内分泌肿瘤（国际通用名 neuroendocrine tumor）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。

正在招募的神经内分泌肿瘤新药试验

• Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma

  I 期招募中美国NCT04975152

• A Study of CRD3874-SI in People With Solid Tumors

  I 期招募中美国NCT06021626

• A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

  不适用招募中美国澳大利亚NCT06887348

• Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

  II 期 / III 期招募中中国NCT07165886

• Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

  IV 期招募中美国NCT07405086

• Navigation Intervention for Adolescent and Young Adult Cancer Survivors

  不适用招募中美国NCT07406087

• Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

  I 期招募中美国NCT04903119

• A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

  I 期 / II 期招募中美国澳大利亚加拿大德国NCT04895709

• Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors.

  不适用招募中法国NCT07463625

• Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

  不适用招募中美国NCT04907643

• Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

  不适用招募中美国NCT04693377

• Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)

  不适用招募中法国NCT04424719